# Repeated Oral Methylphenidate Administration Evokes Changes in Brain Plasticity Proteins in Juvenile Wistar Kyoto Rats: Evidence for Sex-Related Differences

**Authors:** Patrícia Soares-Couto, Susana Isabel Sá, Vera Marisa Costa, Ana Dias-Carvalho, Mariana Ferreira, Félix Dias Carvalho, Andreas Meisel, João Paulo Capela

PMC · DOI: 10.1007/s11064-026-04712-y · Neurochemical Research · 2026-02-26

## TL;DR

This study shows that methylphenidate affects brain plasticity proteins differently in male and female juvenile rats.

## Contribution

The study reveals sex-related differences in brain protein responses to methylphenidate in juvenile rats.

## Key findings

- MPH reduced GAP43 and synaptophysin in male rats' cerebellum and CA1 region.
- MPH increased PSD-95 and GAPDH in the striatum and diencephalon of males.
- MPH-treated females showed a significant decrease in PSD-95 levels in the PFC.

## Abstract

Methylphenidate (MPH) is first-line pharmacotherapy for Attention Deficit Hyperactivity Disorder (ADHD). Misdiagnosis and misuse raise concerns about exposing children and adolescents to MPH. This study aimed to assess how clinically relevant oral doses of MPH influence the expression of brain proteins involved in synaptic plasticity and neuronal growth in both sexes. Thirty-seven Wistar-Kyoto (WKY) rats (18 males and 19 females) were divided into an MPH group (daily oral dose of 5 mg/kg MPH in a 5% sucrose solution) and a control group (equivalent volume of 5% sucrose solution). Daily gavage administration started on postnatal day (PND) 15 and lasted for 15 days, with sacrifice at PND 30. In five brain regions [prefrontal cortex (PFC), striatum, hippocampus, cerebellum, and diencephalon], GAP43, GAPDH and PSD-95 levels were measured by Western blot. Additionally, MAP2 and synaptophysin levels were assessed in the PFC, motor cortex, ventral and dorsal striatum, and hippocampus (including CA1, CA3, hilus, and dentate gyrus) using immunohistochemistry.

In MPH-treated males, GAP43 and synaptophysin levels were reduced in the cerebellum and CA1 region, respectively, while PSD-95 and GAPDH levels increased in the striatum and diencephalon. MPH-treated females showed only a significant decrease in PSD-95 levels in the PFC. Regarding MAP2 levels, no significant changes were observed in any of the analyzed regions or sexes. In control animals, males exhibited higher MAP2 levels in the striatum compared to females. In conclusion, MPH in healthy rats can alter proteins associated with synaptic plasticity differently, highlighting the importance of sex as a variable.

The online version contains supplementary material available at 10.1007/s11064-026-04712-y.

## Linked entities

- **Proteins:** GAP43 (growth associated protein 43), GAPDH (glyceraldehyde-3-phosphate dehydrogenase), DLG4 (discs large MAGUK scaffold protein 4), MAP2 (microtubule associated protein 2)
- **Chemicals:** methylphenidate (PubChem CID 4158), sucrose (PubChem CID 5988)
- **Diseases:** Attention Deficit Hyperactivity Disorder (MONDO:0007743), ADHD (MONDO:0007743)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Alb (albumin) [NCBI Gene 24186] {aka Alb1, Albza}, Map2 (microtubule-associated protein 2) [NCBI Gene 25595] {aka MAP2R, Mtap2}, Casp3 (caspase 3) [NCBI Gene 25402] {aka CPP32-beta, Lice, Yama}, Ngf (nerve growth factor) [NCBI Gene 310738] {aka Ngfb, beta-NGF}, Syp (synaptophysin) [NCBI Gene 24804] {aka Syp1}, Gap43 (growth associated protein 43) [NCBI Gene 29423] {aka Basp2}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 24383] {aka BARS-38, Gapd}, Dlg4 (discs large MAGUK scaffold protein 4) [NCBI Gene 29495] {aka Dlgh4, PSD95, Sap90}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, Glyceraldehyde-3-phosphate dehydrogenase [NCBI Gene 108351137], Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}, Bdnf (brain-derived neurotrophic factor) [NCBI Gene 24225], Sptan1 (spectrin, alpha, non-erythrocytic 1) [NCBI Gene 64159] {aka A2a, IPF, Spna2}
- **Diseases:** psychosis (MESH:D011618), ADHD (MESH:D001289), weight loss (MESH:D015431), hypertensive (MESH:D006973), necrosis (MESH:D009336), cognitive deficits (MESH:D003072), neurological or psychiatric complications (MESH:D009422), impaired memory (MESH:D008569), impulsivity (MESH:D007174), depression (MESH:D003866), Mental Disorders (MESH:D001523), inflammatory (MESH:D007249), inattention (MESH:D001308), neuropathological alterations (MESH:D004408), hyperactivity (MESH:D006948), weight gain (MESH:D015430)
- **Chemicals:** phenylmethylsulfonylfluoride (MESH:D010664), MPH (MESH:D008774), Chemicals (-), H2O2 (MESH:D006861), glycerol (MESH:D005990), Texas Red (MESH:C034657), dopamine (MESH:D004298), TBS-T (MESH:C027647), Tween 20 (MESH:D011136), 4',6-Diamidino-2-phenylindole (MESH:C007293), paraformaldehyde (MESH:C003043), sucrose (MESH:D013395), agarose (MESH:D012685), ethylene glycol (MESH:D019855), bromophenol blue (MESH:D001978), Triton X-100 (MESH:D017830), NaCl (MESH:D012965), sodium deoxycholate (MESH:D003840), sodium metavanadate (MESH:D014638), Phosphate (MESH:D010710), noradrenaline (MESH:D009638), Laemmli buffer (MESH:C088816), dithiothreitol (MESH:D004229), SDS (MESH:D012967), HCl (MESH:D006851), glycine (MESH:D005998), water (MESH:D014867), isoflurane (MESH:D007530), sodium fluoride (MESH:D012969), Ponceau S (MESH:C032756)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Bos taurus (bovine, species) [taxon 9913], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** WKY — Homo sapiens (Human), Finite cell line (CVCL_JE97)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12945962/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12945962/full.md

---
Source: https://tomesphere.com/paper/PMC12945962